Sodium–glucose cotransporter-2 inhibitor use and clinical outcomes in patients with cirrhosis: a propensity-matched real-world cohort study

Elias Helal, Elona Shehi, Ahmad Al Homaid, Migena Dervishi, Devendra K. Tripathi

Open source

DOI
10.1097/meg.0000000000003264
Published
2026-08-11
Container
European Journal of Gastroenterology & Hepatology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/meg.0000000000003264,
  title = {Sodium–glucose cotransporter-2 inhibitor use and clinical outcomes in patients with cirrhosis: a propensity-matched real-world cohort study},
  author = {Elias Helal and Elona Shehi and Ahmad Al Homaid and Migena Dervishi and Devendra K. Tripathi},
  year = {2026},
  journal = {European Journal of Gastroenterology \& Hepatology},
  doi = {10.1097/meg.0000000000003264},
  url = {https://doi.org/10.1097/meg.0000000000003264}
}

RIS

TY  - JOUR
TI  - Sodium–glucose cotransporter-2 inhibitor use and clinical outcomes in patients with cirrhosis: a propensity-matched real-world cohort study
AU  - Elias Helal
AU  - Elona Shehi
AU  - Ahmad Al Homaid
AU  - Migena Dervishi
AU  - Devendra K. Tripathi
PY  - 2026
JO  - European Journal of Gastroenterology & Hepatology
DO  - 10.1097/meg.0000000000003264
UR  - https://doi.org/10.1097/meg.0000000000003264
ER  - 

APA

Helal, E., Shehi, E., Homaid, A. A., Dervishi, M., & Tripathi, D. K. (2026). Sodium–glucose cotransporter-2 inhibitor use and clinical outcomes in patients with cirrhosis: a propensity-matched real-world cohort study. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/meg.0000000000003264

Source records